Akanda (NASDAQ:AKAN) Upgraded by Wall Street Zen to Sell Rating

Wall Street Zen upgraded shares of Akanda (NASDAQ:AKAN) from a strong sell rating to a sell rating in a research note issued to investors on Saturday morning.

Separately, Weiss Ratings downgraded shares of Akanda from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Monday, May 18th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Akanda currently has an average rating of “Sell”.

Akanda Stock Down 4.2%

AKAN opened at $7.73 on Friday. Akanda has a 12 month low of $2.30 and a 12 month high of $209.02. The company has a 50 day moving average of $14.93 and a 200 day moving average of $10.54.

Akanda (NASDAQ:AKAN) last released its earnings results on Tuesday, June 9th. The company reported ($317.90) earnings per share for the quarter.

Akanda Company Profile

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.